Nishida T - Search Results

1

Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan.

Ichinose Y, Yang YH, Tsai HJ, Huang RY, Higashi T, Nishida T, Chen LT. Ichinose Y, et al. Among authors: nishida t. Sci Rep. 2022 Dec 28;12(1):22492. doi: 10.1038/s41598-022-27092-z. Sci Rep. 2022. PMID: 36577796 Free PMC article.

2

[Gastrointestinal stromal tumor].

Nishida T, Ohmori T, Matsuda H. Nishida T, et al. Gan To Kagaku Ryoho. 2004 Mar;31(3):331-6. Gan To Kagaku Ryoho. 2004. PMID: 15045935 Japanese.

3

Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection.

Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T, Nishida T. Nishimura J, et al. Among authors: nishida t. Surg Endosc. 2007 Jun;21(6):875-8. doi: 10.1007/s00464-006-9065-z. Epub 2006 Dec 16. Surg Endosc. 2007. PMID: 17180273

4

Surgical interventions for focal progression of advanced gastrointestinal stromal tumors during imatinib therapy.

Hasegawa J, Kanda T, Hirota S, Fukuda M, Nishitani A, Takahashi T, Kurosaki I, Tsutsui S, Hatakeyama K, Nishida T. Hasegawa J, et al. Among authors: nishida t. Int J Clin Oncol. 2007 Jun;12(3):212-7. doi: 10.1007/s10147-007-0657-y. Epub 2007 Jun 27. Int J Clin Oncol. 2007. PMID: 17566845

5

[Imatinib . Sunitinib].

Nishida T. Nishida T. Gan To Kagaku Ryoho. 2007 Aug;34(8):1196-200. Gan To Kagaku Ryoho. 2007. PMID: 17687201 Japanese.

6

An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors.

Takahashi T, Nakajima K, Nishitani A, Souma Y, Hirota S, Sawa Y, Nishida T. Takahashi T, et al. Among authors: nishida t. Int J Clin Oncol. 2007 Oct;12(5):369-74. doi: 10.1007/s10147-007-0705-7. Epub 2007 Oct 22. Int J Clin Oncol. 2007. PMID: 17929119

7

Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor.

Nishida T, Kanda T, Nishitani A, Takahashi T, Nakajima K, Ishikawa T, Hirota S. Nishida T, et al. Cancer Sci. 2008 Apr;99(4):799-804. doi: 10.1111/j.1349-7006.2008.00727.x. Epub 2008 Feb 21. Cancer Sci. 2008. PMID: 18294292 Free article.

8

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202).

Nishida T, Shirao K, Sawaki A, Koseki M, Okamura T, Ohtsu A, Sugiyama T, Miyakawa K, Hirota S. Nishida T, et al. Int J Clin Oncol. 2008 Jun;13(3):244-51. doi: 10.1007/s10147-007-0746-y. Epub 2008 Jun 14. Int J Clin Oncol. 2008. PMID: 18553235 Clinical Trial.

9

[Contemporary treatment of gastrointestinal stromal tumors].

Nishida T. Nishida T. Gan To Kagaku Ryoho. 2008 Oct;35(10):1639-44. Gan To Kagaku Ryoho. 2008. PMID: 18931562 Review. Japanese.

10

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate.

Sawaki A, Yamada Y, Komatsu Y, Kanda T, Doi T, Koseki M, Baba H, Sun YN, Murakami K, Nishida T. Sawaki A, et al. Among authors: nishida t. Cancer Chemother Pharmacol. 2010 Apr;65(5):961-7. doi: 10.1007/s00280-009-1103-9. Epub 2009 Aug 19. Cancer Chemother Pharmacol. 2010. PMID: 19690858 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,778 results

Search Page